Staburo @ BVMA Symposium 2022 in Munich

Dec 1, 2022
BVMA Symposium

Staburo took part in the BVMA symposium on 25 November 2022, at the Westin Grand Hotel, here in Munich. This year it was the 30. BVMA symposium and for this anniversary the get-together took place the evening before at the SEA LIFE aquarium in Munich.

This year’s topic was: “New approaches in clinical research – Europe moves together”. The symposium presentations and discussions covered the areas of regulatory, decentralized clinical trials, first experiences in the area of CTR/CTIS and as well innovation and digitalisation within clinical research.

We were very happy to learn more about current changes in regulations and updates in the CRO market – thanks to the excellent networking sessions! Congratulation to the BVMA for the organisation of this great event and thank you for the invitation! We are already looking forward to next year’s BVMA symposium.

The BVMA represents the interests of its German CRO members. BVMA members maintain a lively exchange of information on topics that important to the German CRO industry, e.g. on questions of liability and insurance, education and training, quality requirements and trends in the pharmaceutical and CRO industry.

Weitere Artikel

Biomarkers at Staburo

Biomarkers at Staburo

In 2024 at Staburo was about building momentum in the area Biomarkers. Deepening our engagement in the PSI Biomarker SIG, strengthening collaborations, and developing the ideas that would later become deliverables. In 2025, we developed and released ShadowVIMP, an R...

read more
Staburo @ PSI/EFSPI Vaccines Statistics Workshop

Staburo @ PSI/EFSPI Vaccines Statistics Workshop

On October 23, 2025, Staburo, represented by Tim Müller, attended the PSI/EFSPI Vaccines Statistics Workshop at the GSK site in Wavre. The workshop brought together a focused group of highly knowledgeable statisticians and researchers working in vaccines and...

read more
Staburo @ BIO Boston 2025

Staburo @ BIO Boston 2025

Staburo GmbH was represented by our Managing Director, Roland Stieger, at the Biotechnology Innovation Organization (BIO) International Convention from June 16-19, 2025, in Boston. It was an exceptional opportunity to connect with full-service CROs, biotech and big...

read more